drugset / Trial / NCT03756233

Gradual Withdrawal of Remifentanil Infusion Reduced Postoperative Pain and Opioid Requirement During Breast Surgery

NCT03756233 ↗

Completed 60 enrolled Samsung Medical Center
RandomizedCrossoverSingle-blindSupportive care

Summary

Although remifentanil provides profound analgesia during operation, postoperative occurrence of hyperalgesia and tolerance after remifentanil administration could be a challenge to the postoperative pain control. Evaluation of analgesia and anti-nociception during anesthesia is still a challenging issue. Surgical Pleth Index (SPI) is a non-invasive and simple access tool used to monitor autonomous nervous system during anesthesia. This technique is based on photoplethysmographic wave and heart beat analysis. SPI values range between 0 (no stress) and 100 (high stress level). The purpose of this study was to determine the appropriate use of Remifentanil for pain control in patients with SPI.

Timeline

Start
2018-11-26
Primary completion
2019-07-01
Completion
2019-07-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Remifentanil Small molecule — —

Indications